Depression, vertigo, headaches and stroke were among conditions linked to early-onset Alzheimer's disease years before ...

Shanghai Fosun Pharmaceuticals secured regional rights to AR1001 via a $60M option fee. Find out why SFOSF stock is a hold.

These organizations offer support groups, educational resources, and more for caregivers of people with Alzheimer’s or ...

Arrowhead is now moving its tau-targeting therapy from healthy volunteers to Alzheimer’s disease patients.

In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein ...

Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies ...

Study raises concerns about glucosamine and Alzheimer’s disease, linking supplements to faster progression from mild ...

For decades, scientists have focused on amyloid beta as a major culprit behind Alzheimer’s disease, spending billions of dollars developing treatments that have often delivered disappointing results.

GLP-1 drugs such as Ozempic may offer benefits beyond diabetes and weight loss. A new genetic study links these medicines to ...

Could a common hormonal disorder affecting millions of women also increase their risk of Alzheimer’s disease later in life? A ...

Brent and Erika Pfeiffer are sharing their journey ahead of the Cleveland Walk to End Alzheimer's, hoping to help families ...